Anti-D Immunoglobulin Administration, RhD Negative Women, Aide Memoire (433)

Warning
Please report any inaccuracies or issues with this guideline using our online form

Potentially sensitising events (PSE) during pregnancy - table

 

Appendix 1: Potentially sensitising events in pregnancy

Appendix 1- Potentially sensitising events in pregnancy

Evacuation of molar pregnancy

Vaginal bleeding with associated severe pain

Surgical management of ectopic pregnancy  

Antepartum haemorrhage/ Uterine (PV) bleeding 

Miscarriage, threatened miscarriage 

Amniocentesis, chorionic villus biopsy and cordocentesis

External cephalic version

Intrauterine death and stillbirth

In-utero therapeutic interventions (transfusion, surgery, insertion of shunts, laser therapy for TTTS)

Abdominal trauma (sharp/blunt, open/closed, RTA)

 

Therapeutic termination of pregnancy

Delivery – normal, instrumental or Caesarean section

Cell Salvage 

Abdominal  Cerclage

Evacuation of retained products of conception (ERPC) / instrumentation of uterus/ Manual Vacuum Aspiration

Editorial Information

Last reviewed: 10/06/2021

Next review date: 01/12/2023

Author(s): Lead Author for Clinical Governance Mrs A Hanlon, Senior Biomedical Scientist; Dr A Morrison, Consultant Haematologist, Chair GG&C OTC; Dr F. Mackenzie, Consultant Obstetrician; Mrs J Gillies, Risk Management Midwife.

Version: 4

Approved By: Obstetrics Clinical Governance Group

Document Id: 433

Related guidelines